Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

FWBI | First Wave BioPharma Inc

Index- P/E0.03 EPS (ttm)10.52 Insider Own0.02% Shs Outstand7.15M Perf Week-14.65%
Market Cap2.20M Forward P/E- EPS next Y-1.35 Insider Trans-92.12% Shs Float7.15M Perf Month-5.20%
Income-8.19M PEG- EPS next Q-0.61 Inst Own0.66% Short Float / Ratio0.31% / 0.01 Perf Quarter-80.50%
Sales0.00M P/S- EPS this Y74.40% Inst Trans210.67% Short Interest0.02M Perf Half Y-89.73%
Book/sh0.21 P/B1.47 EPS next Y55.57% ROA-190.29% Target Price14.00 Perf Year-96.79%
Cash/sh0.17 P/C1.78 EPS next 5Y- ROE- 52W Range0.27 - 16.38 Perf YTD-94.97%
Dividend- P/FCF- EPS past 5Y60.56% ROI-768.01% 52W High-98.12% Beta1.56
Dividend %- Quick Ratio0.72 Sales past 5Y0.00% Gross Margin- 52W Low12.73% ATR0.09
Employees10 Current Ratio0.72 Sales Q/Q- Oper. Margin0.00% RSI (14)35.74 Volatility12.00% 28.43%
OptionableNo Debt/Eq0.45 EPS Q/Q96.47% Profit Margin- Rel Volume0.15 Prev Close0.32
ShortableYes LT Debt/Eq0.20 Earnings- Payout- Avg Volume3.62M Price0.31
Recom2.00 SMA20-19.09% SMA50-31.73% SMA200-87.95% Volume527,685 Change-5.17%
Sep-15-23 08:45AM
Sep-14-23 10:43AM
Sep-05-23 07:00AM
Jul-19-23 08:15AM
07:00AM Loading…
Jul-13-23 07:00AM
Jul-05-23 07:00AM
Jun-28-23 07:00AM
Jun-27-23 07:00AM
Jun-15-23 11:31AM
Jun-13-23 12:50PM
May-15-23 07:00AM
May-11-23 07:00AM
May-02-23 07:30AM
07:00AM Loading…
Apr-25-23 07:00AM
Mar-13-23 08:00AM
Mar-10-23 07:00AM
Mar-09-23 07:00AM
Feb-28-23 07:00AM
Feb-21-23 07:00AM
Feb-13-23 07:00AM
Feb-07-23 07:00AM
Feb-02-23 07:00AM
Jan-31-23 07:00AM
Jan-30-23 07:00AM
Jan-25-23 07:00AM
Jan-24-23 07:00AM
Jan-13-23 04:00PM
10:20AM Loading…
Jan-09-23 09:10AM
Jan-05-23 09:45AM
Dec-12-22 07:30AM
Dec-05-22 07:00AM
Nov-30-22 07:00AM
Nov-25-22 05:45PM
Nov-22-22 04:15PM
Nov-21-22 08:00AM
Nov-16-22 07:00AM
Oct-31-22 07:00AM
Oct-11-22 05:30PM
Oct-10-22 07:00AM
Oct-06-22 09:00PM
Sep-28-22 07:00AM
Sep-19-22 07:00AM
Sep-14-22 07:00AM
Sep-07-22 07:00AM
Aug-31-22 07:00AM
Aug-29-22 07:00AM
Aug-25-22 12:00PM
Jul-15-22 08:00AM
May-17-22 07:00AM
Apr-29-22 04:30PM
Apr-27-22 07:00AM
Mar-31-22 08:15AM
Mar-28-22 04:23PM
Mar-22-22 07:00AM
Mar-08-22 07:00AM
Mar-03-22 07:00AM
Mar-02-22 05:00PM
Mar-01-22 07:00AM
Feb-28-22 08:01AM
Feb-07-22 07:30AM
Jan-17-22 10:30AM
Jan-14-22 11:25AM
Jan-13-22 07:00AM
Jan-07-22 09:16AM
Jan-06-22 07:00AM
Jan-04-22 07:00AM
Dec-27-21 02:00PM
Dec-23-21 11:45AM
Dec-17-21 09:06AM
Dec-13-21 07:00AM
Dec-09-21 07:00AM
Dec-06-21 07:00AM
Nov-30-21 07:00AM
Nov-16-21 07:00AM
Oct-21-21 07:30AM
Oct-19-21 09:24AM
Oct-14-21 09:00AM
Oct-12-21 08:30AM
Oct-04-21 11:45AM
Oct-01-21 12:30PM
Sep-28-21 08:00AM
First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. Its programs include FW-UP, FW-UC, FW-CD, FW-COV, FW-ICI-AC, MS1819, COVID-19 GI infections, and FW-EPI. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASAMENTO CHARLES JDirectorSep 15Sale0.431046,098Sep 18 05:44 PM
CASAMENTO CHARLES JDirectorAug 31Sale0.306,0531,8166,108Sep 05 08:08 PM
SAPIRSTEIN JAMESPresident and CEOJul 03Sale1.543,3495,15736,161Jul 05 04:27 PM
Romano SarahChief Financial OfficerJul 03Sale1.541,9773,04517,476Jul 05 04:28 PM
SAPIRSTEIN JAMESPresident and CEOApr 03Sale2.503,3478,36839,510Apr 05 04:07 PM
Romano SarahChief Financial OfficerApr 03Sale2.501,9754,93819,453Apr 05 04:17 PM